Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Disease 3Prostatic Neoplasms 2Colorectal Neoplasms 2Sarcoma, Kaposi 1Pain 1Neoplasms 1Lung Neoplasms 1Gynecologic Cancer 1Genetic Diseases, Inborn 1Development of the Virtual Biopsy 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colonic Neoplasms 1Chronic Pain 1Castleman Disease 1Cancer Pain 1COVID-19 1Breast Neoplasms 1Brain Neoplasms 1Anus Neoplasms 1Adenoma 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Diagnostic Tests, Routine × Clear all
NCT07526545 2026-04-13

UPRISE

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
800 enrolled
Genitourinary

Prostatic Neoplasms

NCT05443412 2025-05-20

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

Chinese University of Hong Kong

Recruiting
510 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡